| Cat. No. |
Product Name |
Information |
| PC-21812 |
PAR4 antagonist 48
PAR4 antagonist
|
PAR4 antagonist 48 is a potent and selective quinoxaline-based PAR4 antagonist with IC50 of 1.8 nM in FLIPR calcium mobilization assays, inhibits calcium mobilization in human platelet-rich plasma (PRP) aggregation assay with γ-thrombin with IC50 of 2.1 nM. |
| PC-20882 |
PAR2 antagonist C781
PAR2 antagonist
|
PAR2 antagonist C781 is a potent β-Arrestin biased protease-activated receptor-2 (PAR2) antagonist, effectively reduces 2AT, trypsin and elastase-induced signalling in vitro physiological assays. |
| PC-20579 |
AYPGKF-NH2
PAR4 agonist
|
AYPGKF-NH2 is a potent, PAR4-selective agonist peptide, stimulates platelet aggregation in vitro with EC50 of 15 uM. |
| PC-20578 |
TFLLRN-NH2
PAR1 agonist
|
TFLLRN-NH2 is a potent, PAR1-selective agonist peptide with EC50 of 1.9 uM. |
| PC-20577 |
RWJ-58259
PAR1 antagonist
|
RWJ-58259 (RWJ58259) is a potent, selective thrombin receptor PAR-1 antagonist with binding IC50 of 0.15 uM, and IC50 of 0.07 uM in RASMC calcium mobilization assays. |